Skip to content
Screener

Vericel VCEL EBITDA

EBITDA at other companies

Stryker logo
StrykerSYK
$1.24B+11.5%
CONMED logo
CONMEDCNMD
$47.72M-7.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$596.9M+4.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$23.06M+22.7%
MiMedx Group logo
MiMedx GroupMDXG
-$18.18M-213%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$47.32M-435%

Other financials

Income statement

See full
Revenue$77.5M+22.5%
Gross profit$56.4M+21.0%
Operating income$434.0K+121%
Net income$2.2M+499%
EPS (diluted)$0.04+500%

Balance sheet

See full
Cash & equivalents$125.4M+55.7%
Total debt$93.1M-7.3%
Total equity$370.0M+20.6%
Total assets$502.9M+15.4%

Cash flow

See full
Operating cash flow$16.2M+97.1%
CapEx$1.9M-76.2%
Free cash flow$14.3M+17,504%

Valuation

See full
Market cap$2.31B+29.1%
Enterprise value$2.28B+25.9%
P/E95.3×-156×
P/S7.5×+0.4×

Profitability

See full
Gross margin74.6%+1.1pp
Operating margin6%+5.5pp
Net margin7.9%+5.1pp
FCF margin20.1%—

Returns & leverage

See full
Return on equity7.2%+4.6pp
Debt / equity0.3×-0.1×
Current ratio5×+0.1×

Where this comes from

Calculated from Vericel’s reported figures.

$434.0Kebit+
$3.6MDepreciation Depletion & Amortization
=$4.05M

The source filing: Vericel’s 10-Q, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 8:49 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050836

FAQ

What is Vericel's EBITDA?
Vericel (VCEL) reported EBITDA of $4.05M in Q2 2026.
How has Vericel's EBITDA changed year-over-year?
Vericel's EBITDA increased by 408.7% year-over-year, from $797K to $4.05M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Vericel's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude